Hello everyone,
Over the past many years medical education in India underwent multiple changes to bring in the uniformity and to make every Indian medical student a competent medical graduate. In order to fulfil this vision NMC has laid down extensive guidelines in the form of CBME curriculum introduced from 2019 onwards. The content provided here will help MBBS students in India and abroad to prepare for university as well as competitive examinations such as NEETPG / FMGE / INI-CET / CMS etc in a better way. The exam modules consist of multiple-choice questions that have been asked in the various state university examinations after the implementation of CBME curriculum.

NEW DRUG APPROVALS
TRELAGLIPTIN
Indian FDA (CDSCO) approval date: December 2024
First approval country: Japan (March 2015)
Indication: Type 2 diabetes mellitus
Mode of action: Dipeptidyl peptidase (DPP)-4 inhibitor 
Approved dosage form: Tablets
Approved dosages: 25 mg, 50 mg, and 100 mg
Route of drug administration: Oral
Frequency of drug administration: Once weekly

All the best.
Dr RAJESH DASARAJU MBBS, MD, FICO, FCD, MDPM
Prof & Head, Dept of Pharmacology
Dr.S.S. Tantia MCH&RC, Sri Ganganagar,
Rajasthan – 335002